title: Neoral in liver transplant patients: pharmacokinetic study and clinical implications.
authors.affiliation: Liver Transplantation Unit, Niguarda Hospital, Milan, Italy.
authors.forename: L S
authors.initials: LS
authors.lastname: Belli
authors.forename: O A
authors.initials: OA
authors.lastname: Slim
authors.forename: L
authors.initials: L
authors.lastname: De Carlis
authors.forename: G F
authors.initials: GF
authors.lastname: Rondinara
authors.forename: A
authors.initials: A
authors.lastname: Alberti
authors.forename: F
authors.initials: F
authors.lastname: Zoppi
authors.forename: G
authors.initials: G
authors.lastname: Bellati
authors.forename: E
authors.initials: E
authors.lastname: Fesce
authors.forename: A
authors.initials: A
authors.lastname: Airoldi
authors.forename: D
authors.initials: D
authors.lastname: Colombo
mesh_terms: D000284:Administration, Oral; D001682:Biological Availability; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004435:Eating; D005215:Fasting; D005500:Follow-Up Studies; D005780:Gelatin; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007408:Intestinal Absorption; D016031:Liver Transplantation / Q000502:physiology*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D016572:Cyclosporine; D005780:Gelatin